Cargando…

Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary tumor of the liver. To further define its clinicopathology and surgical management, we reviewed our experience. Clinical presentations of 32 patients with ICC was similar to that with hepatocellular carcinoma. Jaundice occurred...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlinkert, Richard T., Nagorney, David M., van Heerden, Jon A., Adson, Martin A.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1992
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442948/
https://www.ncbi.nlm.nih.gov/pubmed/1319194
http://dx.doi.org/10.1155/1992/93976
_version_ 1782156748774178816
author Schlinkert, Richard T.
Nagorney, David M.
van Heerden, Jon A.
Adson, Martin A.
author_facet Schlinkert, Richard T.
Nagorney, David M.
van Heerden, Jon A.
Adson, Martin A.
author_sort Schlinkert, Richard T.
collection PubMed
description Intrahepatic cholangiocarcinoma (ICC) is the second most common primary tumor of the liver. To further define its clinicopathology and surgical management, we reviewed our experience. Clinical presentations of 32 patients with ICC was similar to that with hepatocellular carcinoma. Jaundice occurred in only 27 percent. ICC was unresectable due to advanced disease stage in 81 percent. Six patients had curative resections with two 5 year disease free survivors. Underlying liver disease was associated with ICC in 34 percent of patients.
format Text
id pubmed-2442948
institution National Center for Biotechnology Information
language English
publishDate 1992
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-24429482008-07-08 Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment Schlinkert, Richard T. Nagorney, David M. van Heerden, Jon A. Adson, Martin A. HPB Surg Research Article Intrahepatic cholangiocarcinoma (ICC) is the second most common primary tumor of the liver. To further define its clinicopathology and surgical management, we reviewed our experience. Clinical presentations of 32 patients with ICC was similar to that with hepatocellular carcinoma. Jaundice occurred in only 27 percent. ICC was unresectable due to advanced disease stage in 81 percent. Six patients had curative resections with two 5 year disease free survivors. Underlying liver disease was associated with ICC in 34 percent of patients. Hindawi Publishing Corporation 1992 /pmc/articles/PMC2442948/ /pubmed/1319194 http://dx.doi.org/10.1155/1992/93976 Text en Copyright © 1992 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Schlinkert, Richard T.
Nagorney, David M.
van Heerden, Jon A.
Adson, Martin A.
Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment
title Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment
title_full Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment
title_fullStr Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment
title_full_unstemmed Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment
title_short Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment
title_sort intrahepatic cholangiocarcinoma: clinical aspects, pathology and treatment
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442948/
https://www.ncbi.nlm.nih.gov/pubmed/1319194
http://dx.doi.org/10.1155/1992/93976
work_keys_str_mv AT schlinkertrichardt intrahepaticcholangiocarcinomaclinicalaspectspathologyandtreatment
AT nagorneydavidm intrahepaticcholangiocarcinomaclinicalaspectspathologyandtreatment
AT vanheerdenjona intrahepaticcholangiocarcinomaclinicalaspectspathologyandtreatment
AT adsonmartina intrahepaticcholangiocarcinomaclinicalaspectspathologyandtreatment